RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innovation Pharmaceuticals Stock

Innovation Pharmaceuticals Liabilities 2024

Innovation Pharmaceuticals Liabilities

5.48 M USD

Ticker

IPIX

ISIN

US45782D1000

WKN

A2DTBJ

In 2024, Innovation Pharmaceuticals's total liabilities amounted to 5.48 M USD, a -3.03% difference from the 5.65 M USD total liabilities in the previous year.

Innovation Pharmaceuticals Aktienanalyse

What does Innovation Pharmaceuticals do?

Innovation Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of novel therapeutics in various areas of medicine. Founded in 2007 as Cellceutix Corporation, the company was renamed Innovation Pharmaceuticals Inc. in 2016. The goal of Innovation Pharmaceuticals is to meet the needs of patients suffering from rare or severe diseases by developing innovative therapies. The focus is on combating inflammation, infections, and cancer. The company's business model is to guide compounds through the stages of clinical development and then license or sell them to large pharmaceutical companies. The different divisions of Innovation Pharmaceuticals are diverse and encompass dermatology, oncology, and infectious diseases, among others. The company has a pipeline of products currently in clinical trials or nearing entry into the clinical phase. One of Innovation Pharmaceuticals' leading products is Brilacidin, a synthetic peptide that can be used as a broad-spectrum antibiotic as well as a potential drug for the treatment of inflammation and cancer. Brilacidin has shown promising results in clinical studies and is currently being investigated in various indications. Another promising product of Innovation Pharmaceuticals is Kevetrin, a drug used for the treatment of cancer. Kevetrin is unique as it focuses on the p53 tumor suppression mechanism. Kevetrin is currently in the clinical phase of development, and Innovation Pharmaceuticals has begun to explore its use in various types of cancer. Innovation Pharmaceuticals also has an extensive portfolio of compounds and technologies in the preclinical stage. These compounds have the potential to create new therapeutic options for various diseases, including autoimmune diseases, chronic inflammatory diseases, and infectious diseases. In summary, Innovation Pharmaceuticals Inc. is a leading biopharmaceutical company focusing on the development of innovative therapeutics in various areas of medicine. The company has an impressive pipeline of products and technologies at various stages of development that have shown promising results. Innovation Pharmaceuticals has the potential to significantly improve the lives of patients with rare and severe diseases by developing novel therapies that are currently unavailable. Innovation Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Innovation Pharmaceuticals's Liabilities

Innovation Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Innovation Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Innovation Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Innovation Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Innovation Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Innovation Pharmaceuticals stock

What is the level of liabilities of Innovation Pharmaceuticals this year?

Innovation Pharmaceuticals has a debt balance of 5.48 M USD this year.

What were the liabilities of Innovation Pharmaceuticals compared to the previous year?

The liabilities of Innovation Pharmaceuticals have increased by -3.03% dropped compared to the previous year.

What are the consequences of high debt for investors of Innovation Pharmaceuticals?

High liabilities can pose a risk for investors of Innovation Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Innovation Pharmaceuticals?

Low liabilities mean that Innovation Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Innovation Pharmaceuticals affect the company?

An increase in liabilities of Innovation Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Innovation Pharmaceuticals affect the company?

A decrease in the liabilities of Innovation Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Innovation Pharmaceuticals?

Some factors that can influence the liabilities of Innovation Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Innovation Pharmaceuticals so important for investors?

The liabilities of Innovation Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Innovation Pharmaceuticals take to modify the liabilities?

To change its liabilities, Innovation Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Innovation Pharmaceuticals pay?

Over the past 12 months, Innovation Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovation Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Innovation Pharmaceuticals?

The current dividend yield of Innovation Pharmaceuticals is .

When does Innovation Pharmaceuticals pay dividends?

Innovation Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovation Pharmaceuticals?

Innovation Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Innovation Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovation Pharmaceuticals located?

Innovation Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innovation Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovation Pharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Innovation Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Innovation Pharmaceuticals in the year 2023?

In the year 2023, Innovation Pharmaceuticals distributed 0 USD as dividends.

In which currency does Innovation Pharmaceuticals pay out the dividend?

The dividends of Innovation Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovation Pharmaceuticals

Our stock analysis for Innovation Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovation Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.